WisTa Laboratories Ltd.
Records under this name other than the patents WisTa Laboratories Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 43 patents it holds.
Back to WisTa Laboratories Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,047,062 | Methods of Chemical Synthesis of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (MTC) Lapsed on the fee record Ended Aug 14, 2026 · High confidence | Lapsed on the fee record | Ended Aug 14, 2026 | High confidence |
| US 8,765,742 | Crystalline Methylthioninium Chloride Hydrates Lapsed on the fee record Ended Jul 1, 2026 · High confidence | Lapsed on the fee record | Ended Jul 1, 2026 | High confidence |
| US 8,703,952 | Synthesis of 9-(ARYLALKYL)-1,2,3,4-Tetrahydro-Y-CARBOLINE and Analogues and Intermediates Lapsed on the fee record Ended Apr 22, 2026 · High confidence | Lapsed on the fee record | Ended Apr 22, 2026 | High confidence |
| US 8,691,979 | Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants Lapsed on the fee record Ended Apr 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | From the USPTO record |
| US 7,605,179 | Napthoquinone Derivatives as Inhibitors of Tau Aggregation for the Treatment of Alzheimer's and Related Neurodegenerative Disorders Term ended Term ended Dec 11, 2025 · High confidence | Term ended | Term ended Dec 11, 2025 | High confidence |
| US 9,555,043 | High purity diaminophenothiazinium compounds including methylthioninium chloride (MTC) Term ended Ended no later than Sep 21, 2025 · From the USPTO record | Term ended | Ended no later than Sep 21, 2025 | From the USPTO record |
| US 9,801,890 | Medical methods utilising high purity diaminophenothiazinium compounds Term ended Ended no later than Sep 21, 2025 · From the USPTO record | Term ended | Ended no later than Sep 21, 2025 | From the USPTO record |
| US 10,537,578 | Medical methods utilising high purity diaminophenothiazinium compounds Term ended Ended no later than Sep 21, 2025 · From the USPTO record | Term ended | Ended no later than Sep 21, 2025 | From the USPTO record |
| US 11,116,772 | Medical methods utilising high purity diaminophenothiazinium compounds Term ended Ended no later than Sep 21, 2025 · From the USPTO record | Term ended | Ended no later than Sep 21, 2025 | From the USPTO record |
| US 7,834,237 | Materials and Methods Relating to Protein Aggregation in Neurodegenerative Disease Term ended Term ended Sep 15, 2023 · High confidence | Term ended | Term ended Sep 15, 2023 | High confidence |